You searched for "foundation"
Practical Handbook of OCT (Retina, Choroid, Glaucoma)
1 October 2014
| Shirley Hancock
|
EYE - Glaucoma, EYE - Vitreo-Retinal, EYE - Imaging, EYE - General
With the rapid development and expansion in the usage of optical coherence tomography (OCT) technology there is always demand for a new OCT publication on the bookshelves. The operation and acquisition skills required are more easily acquired than for the...
Myopia management
1 December 2022
| Shivam Goyal, Shona Redmond
|
EYE - General
With the growing prevalence of myopia at epidemic levels in some countries and increasing number of research publications on myopia control, there is a lot of controversy regarding the management of myopia. As none of them are at present available...
Ocular electrophysiology
A 34-year-old woman, who is a CEO in a multinational firm, has been losing vision over the last 12 months. She has seen her opticians, who initially tried different glasses but could not improve things. Clinical examination is unremarkable. How...
Handbook of Pediatric Retinal OCT and the Eye-Brain Connection
7 December 2020
| Sofia Rokerya
|
EYE - Imaging, EYE - Vitreo-Retinal, EYE - Strabismus, EYE - Paediatrics
Paediatric optical coherence tomography (OCT) imaging of the eye remains an evolving technology to date. This handbook delves into this challenging area successfully and gives a comprehensive and detailed input into paediatric OCT pertaining to the retina and the optic...
What’s new in wet AMD papers?
1 December 2016
| Rod McNeil
|
EYE - Vitreo-Retinal
Paper presentations on neovascular (‘wet’) age-related macular degeneration (AMD) from the 16th European Society of Retina Specialists Congress, Copenhagen, September 2016, outline recent research directions evaluating the impact of vision loss on key health domains, patient preferences in the process...
Screening for stroke-related visual problems
1 August 2014
| Fiona Rowe (Prof)
|
EYE - Neuro-ophthalmology
|
Screening tool, stroke, vision defects
The aim was to report the initial development and evaluation of a suitable screening tool for detecting visual problems after stroke. The tool has four components. The first three include questions asked by examiners about patients’ ocular history and symptoms,...
What's trending Feb/Mar 2023
3 February 2023
| Nadeem Atwan Atwan
|
EYE - General
A round-up of the eye related hot topics that have been trending on social media over the last few weeks. #nativity #needleeye Happy New Year! Let’s kick things off with a holiday-related story. Birmingham-based micro-engraver Graham Short engraved by hand...
Glasgow-based eye surgeon, Dr Tim Lavy, speaks into new vision and new life for Mamadou
The moment a seven-year-old boy sees clearly for the first time has been captured in a video by the charity that gave him free surgery. Surgeons from international charity Mercy Ships believe Mamadou, who lives in Sierra Leone, would have...
Vision measurements vs. self-rating
1 April 2014
| Carmel Noonan
|
EYE - General
The aim of this study was to evaluate the association between self-rated vision status and tests of visual acuity, contrast sensitivity, stereoacuity, bilateral visual field and self-reported visual function in specific domains of near and far vision. The goal was...
Prevalence of visual function impairment in congenital ptosis
This study sought to evaluate the prevalence of visual function loss in the setting of congenital ptosis. This was a retrospective study of 155 eyes of 134 patients; 72 males and 62 females. Mean age at diagnosis was 7.8 ±5.8...Acetylcholine receptor antibodies in the diagnosis of ocular myasthenia gravis at the Manchester Royal Eye Hospital
3 August 2023
| Nouf Alnafisee, Joanna M Jefferis
|
EYE - Neuro-ophthalmology
Myasthenia gravis (MG) is the commonest autoimmune condition to affect the neuromuscular junction. In the UK, its prevalence is 15 per 10,000 [1,2] and recent studies have shown that rates are steadily increasing [3,4]. Aims of this audit The aim...
Patient reported outcomes in adolescents with inherited retinal diseases
4 October 2023
| Ian Reekie
|
EYE - Vitreo-Retinal
|
PROM, Patient-reported outcomes, clinical trial, gene therapy, inherited retinal disease, pediatrics, retinal dystrophy
This was a two-centre validation study of two sets of patient reported outcome measures (PROMS) for adolescents (13-17- years-old) with inherited retinal diseases. The measures were the Michigan Retinal Degeneration Questionnaire (MRDQ) and the Michigan Vision-Related Anxiety Questionnaire (MVAQ). Both...
